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Abstract: 
Purpose: To characterize intracellular Ca2+ ([Ca2+]i) regulation in fetal bladders following outflow 
obstruction by examining Ca2+ response to agonists in smooth muscle cells.  
Materials and Methods: Severe bladder outflow obstruction (BOO) was induced in male fetal sheep 
by placing a urethral ring and urachal ligation midway through gestation at 75 days. Fetuses were 
examined 30 days after surgery. [Ca2+]i in single smooth muscle cells isolated from bladder wall was 
measured with epifluorescence microscopy using Fura-2 AM during exposure to agonists, such as 
carbachol and ATP, and other activators, such as caffeine and KCl.   
Results: Detrusor smooth muscle cells from obstructed bladders had similar resting [Ca2+]i to those 
of sham-operated controls. The maximal response to carbachol was reduced following obstruction 
(p<0.05), and construction of dose-response curves also demonstrated a higher EC50 values 
(p<0.05). These changes were however not mirrored by caffeine-evoked Ca2+ release, which was not 
significantly different between the obstruction group and sham-operated controls. Kinetic analysis of 
carbachol transients further revealed an attenuated maximal rate of rise in obstructed bladders 
(p<0.01). The magnitude of [Ca2+]i to purinergic neurotransmitter ATP was also found to be smaller 
in cells from obstructed bladders (p<0.05), although trans-membrane influx by high K depolarization 
was not significantly affected.  
Conclusions:  Muscarinic and purinergic pathways were down-regulated in fetal detrusor muscle 
following outflow obstruction. These major functional receptors appeared to be more susceptible to 
obstruction than other Ca2+ regulators and their impairment may contribute to compromised 
contractile function seen with in utero BOO.  
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Introduction 
Human fetal bladder outflow obstruction (BOO) is an exclusively male disease, usually caused by 
posterior urethral valves (PUV). This condition affects 1/5000 male births and is the commonest 
cause of end-stage renal failure in children.1 In addition to renal impairment, two-thirds of boys with 
PUV also suffer significant bladder dysfunction,2 with common urodynamic findings of bladder 
instability, low capacity and poor bladder emptying.3 
 
Our current understanding on the consequences of fetal bladder outflow obstruction in humans 
derives from postnatal studies of urinary tract function in boys with posterior urethral valves. In 
infancy these bladders generally have small capacity and thick walls,4 correlating with detrusor 
muscle overactivity on urodynamics.3 Later the bladder develops large capacity and becomes 
hypocontractile, often with progression to complete detrusor failure.3 Less is known about the effects 
of bladder outflow obstruction on human fetal urinary tract structure and function. In several studies 
of human fetuses with bladder outflow obstruction some histological changes have been documented. 
Freedman et al described thickened bladder walls with increased smooth muscle and collagen, but no 
change to their relative content.5 Kim et al reported increased muscle thickness but with decreased 
collagen relative to muscle.6 Workman and Kogan also found increased muscle thickness in human 
fetal bladders with posterior urethral valves, although in contrast to previous findings, there was a 
disproportionate increase in connective tissue.7 However, few studies have examined the 
pathophysiology of the fetal detrusor muscle exposed to bladder outflow obstruction.  
 
The need to understand functional abnormalities as a consequence of PUV necessitates the use of 
experimental animal models to study the normally developing and obstructed fetal bladders. For 
these purposes, the ovine fetus has proved to be a useful model, as it is convenient for experimental 
intra-uterine surgical manipulation, and successful induction of bladder outflow obstruction produces 
dysregulation of normal growth and development.8 In two recent studies, severe obstruction of the 
fetal sheep bladder, by urachal and urethral obstruction, resulted in a large hypocontractile organ, 
accompanied by functional denervation and contractile abnormalities9,10 and bladder remodelling 
from enhanced apoptosis in detrusor muscle.11 An altered collagen content in the detrusor wall has 
been shown to be a significant contributor to contractile abnormalities. However whether other cell 
components, smooth muscle in particular, are also involved, cannot be resolved in the multicellular 
preparations used in the study.10 A crucial question yet to be answered is whether intracellular Ca2+ 
regulation, a determinant of smooth muscle contraction, is altered due to obstruction. Of particular 
interest is whether alterations to cholinergic and purinergic pathways in detrusor muscle occur, such 
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as observed in both adult animal models of BOO and human neurogenic bladders12-15 when 
purinergic mechanisms assume a greater importance. We therefore tested the hypothesis that changes 
to intracellular Ca2+ regulation contribute to impaired contractility of smooth muscle from obstructed 
fetal bladders. We used single smooth muscle cells isolated from the obstructed sheep fetal bladder.    
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Materials and Methods 
 
Experimental model. All work was conducted in accordance with the United Kingdom Home Office 
Animals (Scientific Procedures) Act 1986. Date-mated Romney Marsh ewes were purchased from 
the Royal Veterinary College, Potters Bar, UK. Partial BOO was induced in male fetuses by placing 
an omega-shaped silver ring around the urethra and completely ligating the urachus. The sham-
operated fetuses experienced urethral and urachal exposure only. The experiments used seven fetuses 
for BOO and eleven age-matched fetuses served as control. Surgery was performed at mid gestation 
(75 days). At 30 days after surgery (105 days), the ewes were sacrificed by intravenous injection of 
Euthatal pentobarbitone sodium (Rhone Merieux, Athens, Georgia). Detailed protocols to induce in 
utero BOO in fetal sheep were described previously.9  
 
Single cell preparation. The bladder dome was dissected and placed in Ca2+-free HEPES-Tyrode’s 
solution. Following removal of urothelium and adventitia, small strips of muscle (1 mm diameter, 5 
mm length) were cut from the detrusor layer and placed in a collagenase-based enzyme mixture 
dissolved in the same solution. The muscle preparation was soaked in the enzyme at 25°C for 1 hour 
and then incubated at 37°C for 30 min. The enzymatic reaction was terminated by replacing the 
enzyme mixture with Ca2+-free HEPES Tyrode’s. The strips were gently triturated with a fire-
polished glass pipette to release single cells.  Dissociated cells were stored in Ca2+-free HEPES 
Tyrode’s at 4°C and used within 6 hours.  
 
Measurement of intracellular free Ca2+ concentration, [Ca2+]i. [Ca2+]i was measured with 
epifluorescence microscopy described previously. Cells were loaded with the Ca2+-sensitive 
fluorocrome Fura-2 AM (Calbiochem, Germany) at 25°C for 30 min and de-esterified for 20 min 
before the experiment. An aliquot of cells was placed onto a perfusion chamber fitted on the stage of 
an inverted epifluorescence microscope (Nikon Diaphot, Japan) and 10 min were allowed for cells to 
settle and adhere to the glass bottom. Cells were continuously superfused in normal Tyrode’s solution 
at 37°C, with a flow rate of 2 ml.min-1. The cell of interest was focused and an adjustable diaphragm 
was used to eliminate background interference. The excitation light at 340 nm and 380 nm was 
generated from a xenon light source and alternately directed to the cell via a dichroic mirror centered 
at 410 nm. The emitted fluorescent light was filtered at 510 nm and fluorescence from 410 nm-510 
nm collected.  The signals were amplified with a PMT (photonmultiplier) based spectrometer (Cairn 
UK). The analogue output was converted to digital data via an A-to-D converter (sampling interval 
20ms) and acquired online to a PC for storage and analysis. 
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The intensity ratios at 340 nm and 380 nm excitation (R, 340/380) were calibrated using an in vitro 
method and converted into Ca2+ concentration according to the following equation:  
[Ca2+]i = Kd ((R-Rmin)/(Rmax-R))          
where Kd is the dissociation constant with a value of 224 nM, Rmin and Rmax are intensity ratios in 0 
Ca2+ (no added Ca2+ and 5 mM EGTA) and saturating Ca2+ (2 mM CaCl2) respectively, and  is the 
ratio of fluorescence intensities at 380 nm alone recorded in 0 Ca2+ and Ca2+ saturating solution.  
 
Solutions: Normal Tyrode’s solution contained (mM): NaCl, 118; NaHCO3, 24; KCl, 4.0; CaCl2, 1.8; 
MgCl2.6H2O, 1.0; NaH2PO4.2H2O, 0.4; glucose, 6.1; Na pyruvate, 5.0. Solutions were gassed with 
95%O2: 5%CO2, pH 7.35.  Ca2+-free HEPES-Tyrode’s contained (mM): NaCl, 105; HEPES, 19.5; 
KCl, 3.6; MgCl2.6H2O, 0.9; NaH2PO4.2H2O, 0.4; NaHCO3, 22.3; glucose, 5.4; Na pyruvate, 4.5, pH 
7.1 adjusted with 1 M  NaOH.  All chemicals were from Sigma-Aldrich Co Ltd, Poole, Dorset, UK.  
 
Aliquots of 10 mM aqueous stocks of carbachol, ATP and  ABMA (,  methylene-ATP) were 
added to Tyrode’s to achieve the desired concentrations.  Powder forms of caffeine and KCl were 
added to Tyrode’s solution to make 20 mM caffeine and high-K (120 mM) solutions; no osmotic 
corrections were made. 
 
Data analysis and statistical methods: Results are expressed as means ± SE, n is the number of 
preparations unless otherwise indicated.  Student’s t-test was used to test the difference between two 
means. The null hypothesis was rejected for p<0.05.   
 
EC50 values (concentrations producing 50% of maximal effect) were obtained by the least-squares fit 
to the data points with the Hill equation: 
 y = (ymax .xn)/(xn+kn) ,   
Where y is the proportional response, ymax the maximum effect, x the concentration of an agonist, k 
the EC50 value, n the Hill coefficient. KaleidaGraph and Clampfit programs were used for curve 
fitting and kinetic analysis.  
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Results 
 
Resting [Ca2+]i.. The levels of resting [Ca2+]i are a result of equilibrium of Ca2+ movement exerted by 
all Ca2+ regulators and represent homeostatis of Ca2+ metabolism. At rest, [Ca2+]i in sham-operated 
normal fetal detrusor cells were 147 ± 11 nM, (n=35) and the value is similar in cells from BOO 
bladders: 141 ± 15 nM, (n=24, p=0.77).  These data show that the steady-state Ca2+ equilibrium 
remained unchanged following outlet obstruction.  
 
Evoked [Ca2+]i.rise via intracellular release . A major experimental objective was to investigate the 
effect of BOO on muscarinic receptor activation, the main functional receptor in bladder in all 
species using the agonist carbachol. Control experiments showed that carbachol-induced [Ca2+]i 
transients in fetal detrusor myocytes were specific to muscarinic receptors, as they were blocked by 1 
µM atropine.  In addition the source of Ca2+ was from intracellular stores, as they were abolished by 
prior application of high concentrations of caffeine. A maximal rise of [Ca2+]i could be elicited by 10 
– 100 µM carbachol in these fetal detrusor myocytes. Figure 1 shows that in cells from obstructed 
bladders, the [Ca2+]i transient in response to 30µM carbachol was attenuated compared with cells 
from sham-operated fetal bladders. In 22 cells from obstructed bladders, the maximal carbachol-
induced [Ca2+]i rise was 382±55 nM, in contrast to 654±74 nM from control cells (n=27, p<0.05), 
showing reduced efficacy of the receptors following obstruction (see also Figure 3).  
 
Figure 1 near here 
 
To ascertain whether an altered potency of carbachol also occurred, the dose-response relation was 
determined by application of carbachol over a range between 0.03 to 100 µM. The minimal effective 
concentration was around 0.1µM and the maximal effect around 10µM.  Figure 2A presents tracings 
of [Ca2+]i transients at different concentrations of carbachol, showing a reduced relative magnitude at 
submaximal concentrations in cells from obstructed bladders.  An EC50 of 1.0±0.2 µM was obtained 
from the dose-response relationship for cells from 11 control bladders, whilst the relationship was 
shifted to the right in cells from seven obstructed bladders (EC50: 2.9±0.8 µM; p<0.05, Figure 2B). 
This observation suggests that in addition to attenuated efficacy, the sensitivity of muscarinic 
receptors to their neutrotransmitter was also compromised. The shape of the two curves was similar, 
however, with a Hill coefficient near to unity in both groups (1.45±0.22 and 1.13±0.16 for control 
and obstruction respectively; p=0.32). 
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Figure 2 near here 
To explain the observed reduction of carbachol-induced Ca2+ release, the effect of bladder 
obstruction on the magnitude of the intracellular Ca2+ store was investigated by examining the [Ca2+]i 
rise after brief application of 20mM caffeine. Figure 3 shows that the average rise of [Ca2+]i in 
myocytes from obstructed bladders was not statistically different from that in control cells (415±104 
nM, n=10 vs 568±134 nM, n=15 respectively, p=0.57). This suggests that total releasable Ca2+ from 
intracellular stores was not significantly reduced by fetal BOO.  
Figure 3 near here 
The similar caffeine-evoked Ca2+ rise suggests that a reduced Ca2+ storage capacity was unlikely to 
underlie the suppressed carbachol-response seen in BOO myocytes, and the reason for a 
compromised ability to release Ca2+ was sought.  The maximum rate of [Ca2+]i rise following 
carbachol application (d[Ca2+]i/dt) correlates with Ca2+ release from IP3-mediated release from 
intracellular stores. Carbachol-induced Ca2+-transients in myocytes from an obstructed and control 
bladders are superimposed in figure 4A, each expressed as 100% of their own maximum value.  The 
upstroke phase is shown on an expanded time-base in figure 4B.  Analysis of the upstrokes showed 
that with cells from obstructed bladders this rate was reduced significantly compared to control 
(0.66±0.09 µmoles.l-1.s-1, n=22 vs 1.47±0.23 µmoles.l-1.s-1, n=27, p<0.01).  
Figure 4 near here 
Evidence for impaired Ca2+ extrusion/re-uptake was also sought by measurement of maximal rate of 
relaxation following Ca2+ release by carbachol. A slower rate is apparent in Figure 4A following the 
peak of the [Ca2+]i transient. The maximum rates of relaxation were 0.59±0.10 µmoles.l-1.s-1  (n=22) 
and 1.33±0.27 µmoles.l-1.s-1 (n=27) in cells from obstructed and control bladders, respectively 
(p<0.01). 
 
Evoked [Ca2+]i transients by transmembrane influx. Further experiments examined purinergic 
pathways as purinergic neurotransmission is a functional component in many non-primate species 
and also becomes operational in abnormal human bladders. The maximal Ca2+ rise by 30µM ATP 
was 60±20 nM (n=10) in myocytes from obstructed bladders, statistically different from 175±52 nM 
(n=18) in control cells (p<0.05 Figure 3).   
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Ca2+ influx via Ca2+ channels by membrane depolarization is an important contributor to Ca2+ 
regulation in many smooth muscle cell types and has been shown to be sufficient to generate 
contraction and participate in purinergic activation in detrusor smooth muscle. As ATP-induced 
[Ca2+]i transients were decreased following bladder obstruction, the involvement of Ca2+ channels 
was examined. In this study, a depolarization-induced Ca2+ rise was evoked by raising extracellular 
KCl from 4 mM to 120 mM.  Such transients were abolished by the Ca2+ channel antagonist 
verapamil, indicating specific involvement of L-type Ca2+ channels.  Our measurement showed a net 
rise of [Ca2+]i by 108±42 nM (n=8) and 96±15 nM (n=14) for obstructed bladder and control 
myocytes, respectively  and no statistical difference was found between these two means (p=0.98, 
Figure 3). Thus an attenuation of ATP transient is unlikely to be mediated by an effect on Ca2+ influx 
via Ca2+ channels. 
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Discussion 
The present study has demonstrated that while steady-state cytosolic Ca2+ levels remain unaltered, 
the major receptor functions coupled to a rise of intracellular Ca2+ are down-regulated in fetal 
detrusor smooth muscle following severe BOO. These changes appear to be specific as Ca2+ entry by 
high K-induced depolarization was not significantly affected. These cellular lesions are likely to 
affect the contractile response to neutrotrasmitters and thus bladder function in utero. Both 
muscarinic and purinergic receptors were implicated. Of particular importance is the muscarinic 
system, as it is the predominant mechanism to provide Ca2+ for contractile proteins in bladder, 
evidenced by the large magnitude of carbachol-induced Ca2+ transients compared with other 
pathways (Figure 3).  The compromised receptor function manifests as decreased receptor efficacy, 
indicated by the attenuated response to maximal dose of the agonist. Consistent with reduced receptor 
sensitivity to the ligand, the potency of the agonist was also decreased.  
To date, no study has examined changes to intracellular Ca2+ regulation in fetal detrusor myocytes 
due to BOO. However, reduced receptor responses to neurotransmitters have been documented in 
hypertrophic muscle in adult hollow organs following obstruction or increased afterload. Impaired 
muscarinic as well as purinergic responses have been observed in hypertrophied human bladders and 
in adult models of severe bladder hypertrophy12-15. A reduction in -adrenergic receptor 
responsiveness and subsequent altered myocardial contractile function has also been observed with 
pressure overload–induced cardiac hypertrophy.16 This implies that compromised receptor function 
may be part of the pathogenesis of muscular hypertrophy. Interestingly hypertrophic changes to 
smooth muscle cells have been observed from the present model of BOO,11 suggesting that changes 
to receptor function are part of hypertrophic remodeling of fetal detrusor muscle following 
obstruction. The underlying mechanisms for altered receptor function are not fully understood at 
present but are likely to be multi-factorial.  A primary cause for the impaired receptor function may 
be due to  reduced receptor density, as has been observed with muscarinic  receptors in detrusor 
muscle.17  However, a reduction of the total number of receptors cannot explain attenuated agonist 
potency, which further indicates reduced receptor sensitivity. The latter can at least in part be 
attributable to decreased receptor affinity to its transmitter. Indeed, lower receptor affinity has been 
observed in hypertrophic detrusor muscle, consistent with a shift in the ratio of M2/M3 subtypes .16 A 
switch from subtype M3 to M2 would have an effect on the receptor affinity and hence the sensitivity 
to cholinergic neurotransmitters. Apart from alterations to receptors per se, abnormalities 
“downstream” from the receptors may also be responsible, which has been suggested for impaired 
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responsiveness to adrenergic stimulation.13 As such, impaired downstream coupling to the SR Ca2+ 
release (see later) has been shown in the present study, which would additionally contribute to the 
reduced efficacy and sensitivity of muscarinic receptors.   
Altered Ca2+ responses to neutrotransmitters may be compared with contractile abnormalities in 
obstructed fetal bladders. In the same model of in utero BOO, reduced contractile responses to nerve-
mediated stimulation, as well as to agonists, have been observed.9,10 Denervation and a reduced 
muscle response to neurotransmitters/agonists were both implicated, but it was not possible to 
determine if the latter observation was due to a cellular defect or to a greater deposition of 
extracellular matrix in the form of collagen and elastin. The present study suggests that compromised 
receptor function in smooth muscle is at least a partial contributor to reduced contractility. Both the 
reduced maximal Ca2+ rise and potency may explain the reduced contractile response to cholinergic 
and purinergic agonists such as carbachol and ABMA (,  methylene-ATP). In addition, a slower 
Ca2+ removal following contractile activation (see later discussion) would render myofilaments 
exposed to prolonged above-threshold levels of Ca2+ and compromise their ability to generate phasic 
contractions. This could be another contributing factor to reduced contractility in BOO. The change 
in EC50 of carbachol-induced Ca2+ transients was in contrast to the previous study, which did not 
show a change to EC50 to carbachol, when tension was recorded.10 However, the highest carbachol 
concentration in the previous study was 10 µM, and may not have produced a maximal response, in 
particular in obstructed bladders. An earlier work by Levin et al 18 found no significant differences 
between contractile responses to ATP, carbachol and KCl in fetal sheep bladders following a shorter-
term obstruction. Together with our observation this suggests that these changes to excitatory stimuli 
only occur following longer-term obstruction, which represent cellular lesions in the de-compensated 
phase of BOO. 
At the cellular level, the reduced receptor efficacy and sensitivity to muscarinic stimulation in BOO 
preparations may be associated with cellular signaling/coupling dysfunction. The decreased maximal 
rate of [Ca2+]i rise of the carbachol-induced Ca2+ transient and the unaltered caffeine-induced Ca2+ 
transient following BOO means that reduced IP3 receptor-coupled Ca2+ release may underlie the 
attenuated carbachol response, while the total releasable Ca2+ in the store remains the same. This 
observation also indicates that ryanodine receptors in the SR are not affected by BOO. Apart from the 
rate of Ca2+ rise, the relaxation was also slower, which may explain slower contractile relaxation (P 
Nyirady et al, unpublished data). Detrusor muscle from BOO rabbits exhibit a more tonic 
contraction19, and the slower kinetics of the Ca2+ transient as observed here may in addition to the 
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altered myosin subtypes contribute to this phenomenon. In hypertrophied heart, impaired removal of 
Ca2+ following excitation has also been noticed and found to be associated with reduced SR Ca2+ 
ATPase (SERCA2) activity.20 The observed changes to the Ca2+ removal in the present study may be 
due to compromised SR re-uptake and/or sarcolemmal Ca2+ extrusion via Ca2+-ATP pump, which are 
the major contributors to Ca2+ removal in detrusor muscle, although Na+/Ca2+ exchange cannot be 
excluded.  
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Conclusions: 
Muscarinic and purinergic signaling in fetal bladder smooth muscle is compromised following BOO. 
This is accompanied by attenuated receptor-mediated Ca2+ release and Ca2+ removal. These changes 
in Ca2+ regulation may contribute to abnormalities in contractile function seen with in utero BOO.  
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Figure legends 
 
Figure 1. Carbachol-induced (30 µM) Ca2+i transients in fetal detrusor smooth muscle myocytes. 
Left: carbachol transient from a control myocyte; right: record from a myocyte of an obstructed 
bladder. 
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Figure 2. Comparison of the concentration-dependence of carbachol responses in myoytes from 
control and obstructed bladders.  A. Representative record of carbachol-induced Ca2+ transients at 
different agonist concentrations; a supermaximal concentration was included as a reference: top, a 
control  myocyte; bottom, a BOO counterpart. B. Dose-response relationships: the curves were fitted 
with the Hill equation to the average data points (mean±SE, n=11 control, 7 BOO).  Each curve is 
plotted with respect to its own maximum value at high carbachol concentrations. 
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Figure 3.  Ca2+ transient magnitudes to maximum concentrations of several agonists in cells from 
control (sham) and obstructed (BOO) bladders: carbachol (10-100µM), caffeine (20mM), ATP 
(30µM) and high K (120mM), *p<0.05 difference from control; mean±SE, n=10-27.  
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Figure 4. Profile of carbachol-induced Ca2+ transients.  A. Time course of transients from control and 
obstructed bladder myocytes; the onset of the events was aligned and the magnitude normalized for 
comparison. B. Initial phase of the Ca2+ transients on an expanded time-scale to reveal the difference 
in the rate of rise. 
